[PDF] Top 20 Las nuevas tendencias laborales y la creación de valor de las empresas.

... Current drug-eluting stent (DES) technology is not optimized with regard to the pharmacokinetics of drug release, more research on the drug-eluting stent design and flux of drug ... See full document

... controlled drug delivery in drug eluting stents exerts an important influence in decreasing restenosis in intravascular ...These stents are coated with drug to avoid the ... See full document

... arterial drug uptake. Stents are often deployed at sites of throm- bus and after implantation a clot will inevitably develop once the struts become cov- ered with plasma ...alter drug distribution ... See full document

... high drug concentrations at the injury site without causing serious side-effects in non-target tissues ...First, stents cause permanent physical irritation with the risk of long-term endothelial dysfunction ... See full document

... of drug release from biodegradable and polymer-free modified surface stents, more accurately modelling lumenal blood flow and stent interaction, including the endothelium, the intima and atheroscle- ... See full document

... The application of DESs has put a substantial dent in restenosis which was a well-known and potentially hazardous complication of BMS [1-7]. On the basis of this finding, their implantation has become increasingly common ... See full document

... Whereas previously there has been widespread applica- tion of very expensive new technologies across the spectrum of age and co-morbidities (often without proof of efficacy in groups excluded from randomized ... See full document

... [8]. From the viewpoint of biomechanics, factors such as blood flow velocity, impact flow, pressure and wall shear stress (WSS) have important effects on ...of drug concentration, the Area Under Curve(AUC) ... See full document

... novel stents will be described based on the component (the platform, the polymer, and the drug) that has undergone the most significant changes compared to earlier generation DES (Figure ...‘novel ... See full document

... of drug-eluting stents is a major breakthrough to tackle this ...of drug-eluting stents and discusses quality of life, patient satisfaction, and acceptability of percutaneous ... See full document

... different from what this model describes, this may give some clue to elucidate the mechanism of y-directional diffusion of the drug (for example, the diffusivity in the stratum corneum may be dif- ... See full document

... The rates of MACCRE and acute MI (AMI) were signifi- cantly higher in the CABG group (31.0% and 29.3%, re- spectively) than in the PCI group (both 8.9%, p<0.001) (Table 3), during the in-hospital (up to 30-day) ... See full document

... DES: drug‑eluting stents; ECG: electrocardiogram; EQ5D: Euroqol 5 Dimensions Questionnaire; GDP: gross domestic product; ICER: incremental cost‑effectiveness ratios; LY: life‑years gained; MACE: ... See full document

... Coronary stents improved the procedural safety and efficacy also eliminated the need for surgical standby (Feinberg et ...early stents was that the stent-mediated arterial injury elicited neo intimal ... See full document

... The primary efficacy and safety end point was the incidence of major adverse cardiac events (MACE), defined as a composite of cardiac death, non-fatal MI, and clinically-driven target vessel revascularization (TVR), at ... See full document

... The single year projections showed that the effect of DES on the requirements for CARPs gradually increases with time. When the increased effectiveness of PCI due to an in- troduction of DES was captured by reducing the ... See full document

... Descriptive analysis was performed on all variables. Student’s t-test was used for continuous variables and chi-square testing for dichotomous variables. Univariate analysis compared the demographic, clinical, ... See full document

... Rhodamine 6G concentration in Figure 6 showed that 290 samples after high-duty cycle ultrasonic stimulation carried out 6 times, 15 minutes each time, released 291 more of the dye than u[r] ... See full document

... gene delivery in a cell-specific manner for improving reendothelialization after vessel wall ...rial delivery required cessation of blood flow for 20 minutes; therefore, alterna- tive therapeutically ... See full document

... Ticagrelor-eluting stents may provide an alternative route for treating patients at a high risk of bleeding to preserve endothelial recovery and to reduce smooth muscle ...ticagrelor, ... See full document